Company: RCUS
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0001724521-25-000052
Chunk: 14

Company: Arcus Biosciences, Inc.
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 14
---
.(1)(5) |     | II    |     |  62 |     | Director                                       |
| Kathryn Falberg(2)                |     | III   |     |  64 |     | Director                                       |
| Linda Higgins, Ph.D.(5)           |     | III   |     |  62 |     | Director                                       |
| Yasunori Kaneko, M.D.(2)(3)       |     | I     |     |  71 |     | Director                                       |
| David Lacey, M.D.(3)(4)(5)        |     | II    |     |  72 |     | Director                                       |
| Nicole Lambert(3)(4)              |     | II    |     |  51 |     | Director                                       |
| Patrick Machado, J.D.(4)          |     | I     |     |  61 |     | Director                                       |
| Johanna Mercier                   |     | II    |     |  55 |     | Director                                       |
| Andrew Perlman, M.D., Ph.D.(2)(5) |     | I     |     |  77 |     | Director                                       |
| Antoni Ribas, M.D., Ph.D.(5)      |     | I     |     |  59 |     | Director                                       |

(1) Dr. Berger joined our Board in February 2025 in connection with the resignation of Merdad Parsey, M.D., Ph.D.

(2) Member of the Audit Committee.

(3) Member of the Compensation Committee.

(4) Member of the Nominating and Corporate Governance Committee.

(5) Member of the Science Committee.

<div align='center'>7.</div>

#### Director Nominees
Below we provide a brief biography of each nominee for election to a three-year term as a Class I Director at the Annual Meeting:

Yasunori Kaneko, M.D. has served as a member of the Board since May 2015. Dr. Kaneko was a Managing Director at Skyline Venture Partners, L.P., a venture capital firm, from January 1999 to January 2019. Dr. Kaneko previously served as Chief Financial Officer and Vice President, Business Development at Tularik, Inc., a biopharmaceutical company, at various times from 1992 until 1999. Dr. Kaneko served as a Senior Vice President and Chief Financial Officer of Ionis Pharmaceuticals, Inc.